• 1
    Norman PS. Immunotherapy: 1999–2004. J Allergy Clin Immunol 2004;113: 10131023.
  • 2
    Novak N, Allam JP, Betten H, Haberstok J, Bieber T. The role of antigen presenting cells at distinct anatomic sites: they accelerate and they slow down allergies. Allergy 2004;59: 514.
  • 3
    Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol 2003;111: 437448.
  • 4
    Novak N, Kraft S, Bieber T. IgE receptors. Curr Opin Immunol 2001;13: 721726.
  • 5
    Geijtenbeek TB, Engering A, Van KY. DC-SIGN, a C-type lectin on dendritic cells that unveils many aspects of dendritic cell biology. J Leukoc Biol 2002;71: 921931.
  • 6
    Currie AJ, Stewart GA, McWilliam AS. Alveolar macrophages bind and phagocytose allergen-containing pollen starch granules via C-type lectin and integrin receptors: implications for airway inflammatory disease. J Immunol 2000;164: 38783886.
  • 7
    Ying S, Barata LT, Meng Q, Grant JA, Barkans J, Durham SR et al. High-affinity immunoglobulin E receptor (Fc epsilon RI)-bearing eosinophils, mast cells, macrophages and Langerhans’ cells in allergen-induced late-phase cutaneous reactions in atopic subjects. Immunology 1998;93: 281288.
  • 8
    Granucci F, Ricciardi-Castagnoli P. Interactions of bacterial pathogens with dendritic cells during invasion of mucosal surfaces. Curr Opin Microbiol 2003;6: 7276.
  • 9
    Allam JP, Novak N, Fuchs C, Asen S, Berge S, Appel T et al. Characterization of dendritic cells from human oral mucosa: a new Langerhans’ cell type with high constitutive FcepsilonRI expression. J Allergy Clin Immunol 2003;112: 141148.
  • 10
    Novak N, Kraft S, Haberstok J, Geiger E, Allam P, Bieber T. A reducing microenvironment leads to the generation of FcepsilonRI high inflammatory dendritic epidermal cells (IDEC). J Invest Dermatol 2002;119: 842849.
  • 11
    Allam JP, Klein E, Bieber T, Novak N. Transforming growth factor-beta1 regulates the expression of the high-affinity receptor for IgE on CD34 stem cell-derived CD1a dendritic cells in vitro. J Invest Dermatol 2004;123: 676682.
  • 12
    Smurthwaite L, Durham SR. Local IgE synthesis in allergic rhinitis and asthma. Curr Allergy Asthma Rep 2002;2: 231238.
  • 13
    Babu KS, Arshad SH, Holgate ST. Anti-IgE treatment: an update. Allergy 2001;56: 11211128.
  • 14
    Arikan C, Bahceciler NN, Deniz G, Akdis M, Akkoc T, Akdis CA et al. Bacillus Calmette-Guerin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy. Clin Exp Allergy 2004;34: 398405.
  • 15
    Kraft S, Wessendorf JH, Hanau D, Bieber T. Regulation of the high affinity receptor for IgE on human epidermal Langerhans cells. J Immunol 1998;161: 10001006.
  • 16
    Jahnsen FL, Lund-Johansen F, Dunne JF, Farkas L, Haye R, Brandtzaeg P. Experimentally induced recruitment of plasmacytoid (CD123high) dendritic cells in human nasal allergy. J Immunol 2000;165: 40624068.
  • 17
    Lambrecht BN. Dendritic cells and the regulation of the allergic immune response. Allergy 2005;60: 271282.
  • 18
    Ebner S, Ehammer Z, Holzmann S, Schwingshackl P, Forstner M, Stoitzner P et al. Expression of C-type lectin receptors by subsets of dendritic cells in human skin. Int Immunol 2004;16: 877887.
  • 19
    Borkowski TA, Jouvin MH, Lin SY, Kinet JP. Minimal requirements for IgE-mediated regulation of surface Fc epsilon RI. J Immunol 2001;167: 12901296.
  • 20
    Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004;113: 832836.
  • 21
    Valladeau J, Duvert-Frances V, Pin JJ, Zutter-Dambuyant C, Vincent C, Massacrier C et al. The monoclonal antibody DCGM4 recognizes langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur J Immunol 1999;29: 26952704.
  • 22
    Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K. Lipopolysaccharide-enhanced, Toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 2002;196: 16451651.
  • 23
    Kweon MN, Fujihashi K, Wakatsuki Y, Koga T, Yamamoto M, McGhee JR et al. Mucosally induced systemic T cell unresponsiveness to ovalbumin requires CD40 ligand-CD40 interactions. J Immunol 1999;162: 19041909.